PortfoliosLab logoPortfoliosLab logo
Annexon, Inc. (ANNX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US03589W1027
CUSIP
03589W102
IPO Date
Jul 24, 2020

Highlights

EPS (TTM)
-$1.39
EBITDA (TTM)
-$214.30M
Year Range
$1.29 - $7.18
Target Price
$16.00
ROA (TTM)
-74.58%
ROE (TTM)
-97.82%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Annexon, Inc.

Often compared with ANNX:
ANNX vs. CRT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Annexon, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Annexon, Inc. (ANNX) has returned 10.36% so far this year and 187.05% over the past 12 months.


Annexon, Inc.

1D
11.69%
1M
-1.07%
YTD
10.36%
6M
81.64%
1Y
187.05%
3Y*
12.90%
5Y*
-27.41%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 24, 2020, ANNX's average daily return is +0.08%, while the average monthly return is +1.32%. At this rate, your investment would double in approximately 4.4 years.

Historically, 51% of months were positive and 49% were negative. The best month was Dec 2023 with a return of +82.3%, while the worst month was Mar 2022 at -43.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 7 months.

On a daily basis, ANNX closed higher 47% of trading days. The best single day was May 26, 2023 with a return of +35.7%, while the worst single day was May 25, 2023 at -59.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202624.30%-10.26%-1.07%10.36%
2025-25.15%-31.25%-26.89%-3.63%9.68%17.65%0.00%-14.17%48.06%3.61%42.41%11.56%-2.14%
2024-8.48%34.06%28.73%-36.54%6.15%1.45%30.82%-11.08%3.86%23.65%-26.37%-4.82%13.00%
202338.10%-25.35%-27.77%37.79%-43.64%17.73%-1.99%-20.29%-14.18%-3.81%9.69%82.33%-12.19%
2022-34.73%-35.27%-43.77%-6.59%23.14%20.06%32.89%17.37%5.10%-22.65%13.81%-4.96%-55.00%
2021-12.11%32.32%-4.36%-28.41%5.97%6.58%-6.44%-22.36%13.82%-12.36%-0.12%-29.47%-54.10%

Benchmark Metrics

Annexon, Inc. has an annualized alpha of 4.71%, beta of 1.11, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since July 27, 2020.

  • This stock participated in 192.09% of S&P 500 Index downside but only 77.06% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
4.71%
Beta
1.11
0.04
Upside Capture
77.06%
Downside Capture
192.09%

Return for Risk

Risk / Return Rank

ANNX ranks 89 for risk / return — in the top 89% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


ANNX Risk / Return Rank: 8989
Overall Rank
ANNX Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
ANNX Sortino Ratio Rank: 9090
Sortino Ratio Rank
ANNX Omega Ratio Rank: 8383
Omega Ratio Rank
ANNX Calmar Ratio Rank: 9393
Calmar Ratio Rank
ANNX Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Annexon, Inc. (ANNX) and compare them to a chosen benchmark (S&P 500 Index).


ANNXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.24

0.90

+1.34

Sortino ratio

Return per unit of downside risk

2.89

1.39

+1.50

Omega ratio

Gain probability vs. loss probability

1.32

1.21

+0.11

Calmar ratio

Return relative to maximum drawdown

4.92

1.40

+3.52

Martin ratio

Return relative to average drawdown

9.94

6.61

+3.33

Explore ANNX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Annexon, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Annexon, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Annexon, Inc. was 96.06%, occurring on Apr 10, 2025. The portfolio has not yet recovered.

The current Annexon, Inc. drawdown is 84.18%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.06%Mar 17, 20211023Apr 10, 2025
-31.37%Oct 19, 202010Oct 30, 202037Dec 23, 202047
-27.99%Dec 24, 202024Jan 29, 202115Feb 22, 202139
-25.64%Aug 13, 202025Sep 17, 20209Sep 30, 202034
-13.04%Feb 23, 202110Mar 8, 20213Mar 11, 202113

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Annexon, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Annexon, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items